Chimeric Antigen Receptor T Cells in Multiple Myeloma

被引：1
|
作者：
Shah, Parth [1 ,2 ,4 ]
Sperling, Adam S. [2 ,3 ]
机构：
[1] Dartmouth Canc Ctr, Dept Hematol, 1 Med Ctr Dr, Lebanon, NH 03750 USA
[2] Dana Farber Canc Inst, Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA
[4] 1 Med Ctr Dr, Lebanon, NH 03750 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
Multiple myeloma; CAR-T; BCMA; GPRC5D; BiTEs; THERAPY; BCMA; MALIGNANCIES; MATURATION; ANTIBODY; COMBINATION; TRANSPLANT; EXPRESSION; PHASE-1; FUSION;
D O I：
10.1016/j.hoc.2023.05.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1089 / 1105
页数：17
相关论文
共 50 条
  • [41] Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma
    Alqazaqi, Raghad
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    Shaughnessy, John
    Zhan, Fenghuang
    Tricot, Guido
    van Rhee, Frits
    Al Hadidi, Samer
    JAMA NETWORK OPEN, 2022, 5 (08) : E2228877
  • [42] Chimeric antigen receptor T-cells, bispecific antibodies, and antibody-drug conjugates for multiple myeloma: An update
    Lakshman, Arjun
    Kumar, Shaji K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (01) : 99 - 118
  • [43] Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma
    Hamadeh, Issam S.
    Friend, Reed
    Mailankody, Sham
    Atrash, Shebli
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [44] Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma
    Li, Xiaorui
    Feng, Yaru
    Shang, Fengqin
    Yu, Zhuoying
    Wang, Tieshan
    Zhang, Jing
    Song, Zhiru
    Wang, Ping
    Shi, Bingjie
    Wang, Jianxun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma
    Radhakrishnan, Sabarinath Venniyil
    Luetkens, Tim
    Yousef, Sara
    Bhardwaj, Neelam
    Steinbach, Mary Nicole
    Weidner, Janet
    Shorter, Christa
    Sborov, Douglas W.
    Atanackovic, Djordje
    BLOOD, 2017, 130
  • [46] Cardiovascular events during treatment with anti-BCMA chimeric antigen receptor T-cells in multiple myeloma
    Mathilde, Chanut
    HEMATOLOGIE, 2023, 29 (05): : 274 - 275
  • [47] Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
    Ma, Tiantian
    Shi, Jing
    Liu, Huasheng
    ANNALS OF HEMATOLOGY, 2019, 98 (04) : 813 - 822
  • [48] Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma
    Cronk, Robert J.
    Zurko, Joanna
    Shah, Nirav N.
    CANCERS, 2020, 12 (09) : 1 - 15
  • [49] Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
    Tiantian Ma
    Jing Shi
    Huasheng Liu
    Annals of Hematology, 2019, 98 : 813 - 822
  • [50] DEVELOPMENT OF A NOVEL ANTI-MULTIPLE MYELOMA CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
    Hay, Chuck
    Faber, Mary
    Adeyanju, Kemi
    Medin, Jeffrey
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A896 - A896
12345